Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarin

Clin Toxicol (Phila). 2007 Jun-Aug;45(5):512-5. doi: 10.1080/15563650701354234.

Abstract

Acetylcholinesterase (AChE; EC 3.1.1.7) reactivators are used as a part of the antidotal therapy of organophosphorus pesticide and nerve agent intoxications. Cyclosarin is one member of the nerve agent family. In this article, we compared the reactivation potency of five structurally different AChE reactivators (pralidoxime, trimedoxime, methoxime, HS-6, and BI-6) to reactivate cyclosarin-inhibited cholinesterases of human brain. The results demonstrate that the bisquaternary monooxime reactivator BI-6 seems to be the most potent reactivator of cyclosarin-inhibited cholinesterases. Moreover, according to the results, we can describe basic structural requirements, which are necessary for the efficacious reactivation process.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Brain / drug effects*
  • Brain / enzymology
  • Cholinesterase Inhibitors / pharmacology
  • Cholinesterase Reactivators / pharmacology*
  • Cholinesterases / metabolism
  • Humans
  • In Vitro Techniques
  • Male
  • Organophosphorus Compounds / pharmacology
  • Oximes / pharmacology*
  • Pralidoxime Compounds / pharmacology*
  • Pyridinium Compounds / pharmacology*
  • Trimedoxime / pharmacology

Substances

  • BI 6
  • Cholinesterase Inhibitors
  • Cholinesterase Reactivators
  • Organophosphorus Compounds
  • Oximes
  • Pralidoxime Compounds
  • Pyridinium Compounds
  • HS 6
  • Trimedoxime
  • N,N'-monomethylenebis(pyridiniumaldoxime)
  • Cholinesterases
  • pralidoxime
  • cyclohexyl methylphosphonofluoridate